Daily Archives: March 31, 2016

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Posted on March 31, 2016 by Edward Shelton, David Laharie, Frank I. Scott, Ronac Mamtani, James D. Lewis, Jean-Frederic Colombel, Ashwin N. Ananthakrishnan

Physicians frequently encounter patients with immune-mediated diseases and a history of malignancy. There are limited data on the safety of immunosuppressive therapy for these patients. Published studies have been small with few events, precluding rob… Continue reading →

Posted in News | Comments Off on Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Posted on March 31, 2016 by Edward Shelton, David Laharie, Frank I. Scott, Ronac Mamtani, James D. Lewis, Jean-Frederic Colombel, Ashwin N. Ananthakrishnan

Physicians frequently encounter patients with immune-mediated diseases and a history of malignancy. There are limited data on the safety of immunosuppressive therapy for these patients. Published studies have been small with few events, precluding rob… Continue reading →

Posted in News | Comments Off on Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

Posted on March 31, 2016 by Vito Di Marco, Vincenza Calvaruso, Donatella Ferraro, Maria Grazia Bavetta, Giuseppe Cabibbo, Elisabetta Conte, Calogero Cammà, Stefania Grimaudo, Rosaria Maria Pipitone, Fabio Simone, Sergio Peralta, Andrea Arini, Antonio Craxì

Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices … Continue reading →

Posted in News | Comments Off on Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

Posted on March 31, 2016 by Vito Di Marco, Vincenza Calvaruso, Donatella Ferraro, Maria Grazia Bavetta, Giuseppe Cabibbo, Elisabetta Conte, Calogero Cammà, Stefania Grimaudo, Rosaria Maria Pipitone, Fabio Simone, Sergio Peralta, Andrea Arini, Antonio Craxì

Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices … Continue reading →

Posted in News | Comments Off on Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension